Insurance companies may like to deal with hospitals and third-party administrators (TPAs) more cautiously after going through the latest data on medical inflation.
According to data analysed by the Insurance Regulatory and Development Authority (Irda), the claim severity is 83 per cent higher in case of cashless mediclaim than reimbursement in the last two years.
Cashless mediclaim allows policyholders to get treatment without paying for it at the hospital. The insurance company settles the bill directly with the hospital.
| SHEDDING LIGHT NUMBER OF CLAIMS | |||
| 2007-08 | 2009-10 | % Chg | |
| Arthropathies | 14,500 | 20,330 | 40.21 |
| Blood Diseases | 1,435 | 1,972 | 37.42 |
| Circulatory | 35,776 | 49,687 | 38.88 |
| Digestive | 25,881 | 36,420 | 40.72 |
| Ear | 1,466 | 2,371 | 61.73 |
| Endocrine | 5,591 | 6,426 | 14.93 |
| Eye | 6,298 | 12,623 | 100.43 |
| Infections | 9,759 | 12,969 | 32.89 |
| 2007-08 | 2009-10 | % Chg | |
| Injury | 24,508 | 33,400 | 36.28 |
| Neoplasm | 21,999 | 31,475 | 43.07 |
| Nervous | 4,152 | 6,030 | 45.23 |
| Pregnancy | 15,391 | 28,539 | 85.43 |
| Respiratory | 8,425 | 13,824 | 64.08 |
| Skin | 2,255 | 3,410 | 51.22 |
| Urology | 22,028 | 33,407 | 51.66 |
| TOTAL | 199,464 | 292,883 | 46.84 |
| Source: Irda | |||
The report said the overall claim severity had increased by 27 per cent for 2009-10 as compared to 2008-09, while circulatory disease had gone up by 56.99 per cent.
The intensity of claims varies according to the disease, reflecting the complexities of treatment. Similarly, claim severity increased in all cases, except for endocrine, eye, infections and respiratory diseases, the report said.
There were, however, no major variations in the average number of days of stay in hospitals under cashless and reimbursement heads for settlement of claims.
The report found that in case of above average hospitals, the severity of claims was 70 per cent higher than the industry average.
The report said the medicine cost to surgery charges varied in case of reimbursement and cashless systems.
Medicine cost was also higher in cashless mediclaim.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
